Lab Automation In Drug Discovery Market Expected To Grow Steadily And Approach $345.02 Billion By 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Lab Automation In Drug Discovery Market Over The 2026–2030 Period?
The lab automation in drug discovery market size has experienced strong growth in recent years. It is forecast to grow from $6.77 billion in 2025 to $7.12 billion in 2026, at a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to factors such as the increasing adoption of robotic arms in laboratories, rising investment in pharmaceutical research and development, a greater demand for automation to reduce errors, the integration of lab information management systems, and advancements in high-throughput screening technologies.
The market size for lab automation in drug discovery is anticipated to show robust expansion in the coming years. It is forecast to grow to $8.72 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.2%. The progress during the forecast period is attributable to several factors, including the expansion of AI-driven drug discovery platforms, an increasing demand for personalized medicine, the rise of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and increasing collaborations between pharma and biotech companies. Key trends for the forecast period include high-throughput screening automation, integrated laboratory workflows, the application of predictive analytics in drug discovery, the miniaturization of lab processes, and cloud-based lab management.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp
What Primary Drivers Are Shaping The Lab Automation In Drug Discovery Market?
The expanding need for precision medicine is predicted to drive the expansion of lab automation within the drug discovery sector in the coming years. This approach, sometimes called personalized medicine, focuses on medical treatment and prevention by factoring in each individual’s distinct genetic traits, environmental conditions, and lifestyle. Automation in laboratories speeds up research, boosts the consistency of experiments, and makes precision medicine and drug discovery processes more effective, resulting in better drugs and diagnostics customized for individual patients. For example, the Precision Medicine Coalition, a US-based non-profit organization, published a report in February 2024 indicating that 16 new personalized treatments for patients with rare diseases received FDA approval in 2023, representing a notable increase compared to the six approved in 2022. Consequently, the rising requirement for precision medicine is a key factor boosting the development of lab automation in the drug discovery market.
Which Segment Types Are Examined In The Lab Automation In Drug Discovery Market Segment Study?
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems
What Trends Are Affecting The Direction Of The Lab Automation In Drug Discovery Market?
Major companies engaged in lab automation within the drug discovery market are prioritizing the integration of AI-driven and robotics-based platforms to speed up formulation development and boost R&D efficiency. These AI-powered and robot-assisted platforms utilize smart algorithms and automated machines to streamline operations, increase precision, and accelerate workflows. For example, in May 2025, Intrepid Labs, a Canada-based research laboratory, launched its Valiant platform, an AI-driven and robotics-enabled system crafted to dramatically accelerate drug formulation development. Supported by more than $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores full formulation design spaces, reducing timelines from months to days while simultaneously improving therapeutic performance and safety. Since its 2023 founding, Intrepid Labs has established partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.
Which Players Are Part Of The Competitive Landscape Of The Lab Automation In Drug Discovery Market?
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation
Get The Full Lab Automation In Drug Discovery Market Report:
Which Region Accounts For The Largest Portion Of The Lab Automation In Drug Discovery Market?
North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Lab Automation In Drug Discovery Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company
Lab Automation In Drug Discovery Market Report 2026
Lab Automation In Genomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report
Lab Automation Market Report 2026
https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
